Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Qiu, Si Qi ^a   Wei, Xiao Long ^a,b   Huang, Wen He ^a   Wu, Ming Yao ^b   Qin, Yun Sheng ^a   Li, Yang Kang ^a   Zhang, Guo Jun ^a,b  

^a CANCER HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; TUMOR MARKER;

ADULT; AGED; BREAST TUMOR; CHEMISTRY; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MIDDLE AGED; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; YOUNG ADULT; BREAST NEOPLASMS; HISTIOCYTOMA, MALIGNANT FIBROUS;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84883433520     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02529     Document Type: Article

References (21)

1. O?Brien, J. E. & Stout, A. P. Malignant Fibrous Xanthomas. Cancer. 17, 1445-55 (1964).
2. Iellin, A.,Waizbard, E., Levine, T. & Behar, A. Malignant fubrous histiocytoma of the breast. Int Surg. 75, 63-66 (1990).
3. Tamir, G., Nobel, M., Hauben, D. J. & Sandbank, J. Malignant fibrous histiocytoma of the breast. Eur J Surg Oncol. 21, 210-11 (1995).
4. Weiss, S. W. & Enzinger, F. M. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer. 41, 2250-66 (1978). (Pubitemid 8370196)
5. Polinari, U., D?Ugo, D., Di Folco, S., Scambia, G. & Sica, G. Malignant fibrous histiocytoma. Report of a case and review of the literature. Eur J Gynaecol Oncol. 6, 105-08 (1985). (Pubitemid 15067657)
6. Pollard, S. G., Marks, P. V., Temple, L. N. & Thompson, H. H. Breast sarcoma. A clinicopathologic review of 25 cases. Cancer. 66, 941-44 (1990). (Pubitemid 20307929)
7. Blanchard, D. K., Reynolds, C. A., Grant, C. S. & Donohue, J. H. Primary nonphylloides breast sarcomas. Am J Surg. 186, 359-61 (2003). (Pubitemid 38368610)
8. Choudhury, M., Nangia, A., Singh, S. K., Pujani, M. & Thomas, S. Cytohistomorphologic features of malignant fibrous histiocytoma of the breast: a case report. Acta Cytol. 54, 985-88 (2010).
9. Sheppard, D. G. & Libshitz, H. I. Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases. Clin Radiol. 56, 22-29 (2001). (Pubitemid 32685180)
10. Taghian, A. et al. Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys. 21, 361-67 (1991).
11. Cahan, W. G. et al. Sarcoma arising in irradiated bone; report of 11 cases. Cancer. 1, 3-29 (1948).
12. Biswas, S. & Badiuddin, F. Radiation induced malignant histiocytoma of the contralateral breast following treatment of breast cancer: a case report and review of the literature. Cases J. 1, 313 (2008).
13. Gutman, H. et al. Sarcoma of the breast: implications for extent of therapy. The M. D. Anerson experience. Surgery. 116, 505-09 (1994).
14. van Niekerk, J. L., Wobbes, T., Holland, R. & van Haelst, U. J. Malignant fibrous histiocytoma of the breast with axillary lymph node involvement. J SurgOncol. 34, 32-35 (1987). (Pubitemid 17007166)
15. Jones, M. W.,Norris, H. J., Wargotz, E. S. &Weiss, S. W. Fibrosarcoma-malignant fibrous histiocytoma of the breast. A clinicopathological study of 32 cases. Am J Surg Pathol. 16, 667-74 (1992).
16. De Cesare, A. et al. Malignant fibrous histiocytoma of the breast. Report of two cases and review of the literature. Anticancer Res. 25, 505-08 (2005). (Pubitemid 40470057)
17. Gort, E. H. et al. Methylation of the TWIST1 promoter, TWIST1 mRNA levels, and immunohistochemical expression of TWIST1 in breast cancer. Cancer Epidemiol Biomarkers Prev. 17, 3325-30 (2008).
18. Nishimura, R. et al. Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis. World J Surg Oncol. 9, 131 (2011).
19. Maciel Mdo, S. et al. P53 expression is a factor for prognostic assessment in breast sarcoma. Breast Cancer Res Treat. 71, 193-202 (2002).
20. Koo, J. S. & Jung, W. Clinicopathlogic and immunohistochemical characteristics of triple negative invasive lobular carcinoma. Yonsei Med J. 52, 89-97 (2011).
21. Kafousi, M. et al. Immunohistochemical study of the angiogenetic network of VEGF, HIF1alpha, VEGFR-2 and endothelial nitric oxide synthase (eNOS) in human breast cancer. Pathol Oncol Res 18, 33-41 (2012